Jean-luc Charuel

Clichy-sous-bois, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients.

Characteristics and outcomes of anti-Ku antibody-associated interstitial lung disease: a retrospective study of 60 patients.

Journal: RMD open

Published: March 14, 2026

Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study.

Gastrointestinal involvement in dermatomyositis: multicentric retrospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: September 05, 2025

IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.

IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodies.

Journal: Rheumatology (Oxford, England)

Published: June 03, 2025

Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study.

Diseases associated with anti-centromere protein F (anti-CENP-F) antibodies: Insights from a large cohort study.

Journal: Joint bone spine

Published: January 13, 2025

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies.

Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies.

Journal: RMD open

Published: October 27, 2024

Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection.

Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection.

Journal: Annals of intensive care

Published: September 17, 2024

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

Journal: Nature

Published: December 05, 2022

Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?

Osteonecrosis in patients with juvenile dermatomyositis: is it associated with anti-MDA5 autoantibody?

Journal: Rheumatology (Oxford, England)

Published: December 04, 2022

Successful treatment of JAK1-associated inflammatory disease.

Successful treatment of JAK1-associated inflammatory disease.

Journal: The Journal of allergy and clinical immunology

Published: November 18, 2022

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults.

Phenotypic Heterogeneity of Fulminant COVID-19--Related Myocarditis in Adults.

Journal: Journal of the American College of Cardiology

Published: February 01, 2022

Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study.

Efficacy and tolerance of corticosteroids and methotrexate in patients with juvenile dermatomyositis: a retrospective cohort study.

Journal: Rheumatology (Oxford, England)

Published: December 10, 2021

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.

JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective study.

Journal: Rheumatology (Oxford, England)

Published: November 09, 2020

Showing 1-12 of 32

Last Updated: 09/26/2026